Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
* Mabvax therapeutics holdings inc - mvt-2163 immunopet agent administered in combination with mvt-5873 was safe and well tolerated * Mabvax Therapeutics holdings inc - "anticipate initiating patient ...
* Mabvax Therapeutics commences patient dosing in MVT-1075 radioimmunotherapy phase 1 clinical trial for the treatment of pancreatic, colon and lung cancers * Company expects to report interim results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback